IL1B and cancer: The fact that TAK1 inhibition significantly reduced metastatic growth in both mouse models, while IL1 inhibition had a smaller effect could mean that cancer cells in the lung microenvironment are provided with other signals that can activate the TAK1-P38 pathway.